Microbiota-driven antitumour immunity mediated by dendritic cell migration

by | Jul 14, 2025 | Uncategorized | 0 comments

Author

Nature, Published online: 14 July 2025; doi:10.1038/s41586-025-09249-8

A newly identified bacterial strain (YB328) isolated from the faeces of patients who responded to immune checkpoint blockade therapies can promote antitumour immunity through the activation of tumour-specific CD8+ T cells.

Archive Posts

0 Comments

Submit a Comment

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.